1. Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis. (October 2021) Authors: Lipardi, Concetta; Elliott, C. Gregory; Sugarmann, Chiara L.; Haskell, Lloyd; Spyropoulos, Alex C.; Raskob, Gary E.; Xu, Jianfeng; Lu, Wentao; Marsigliano, Jessica; Spiro, Theodore; Yuan, Zhong; Wu, Shujian; Barnathan, Elliot S. Journal: Clinical and applied thrombosis/hemostasis Issue: Volume 27(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Laboratory testing of rivaroxaban in routine clinical practice: When, how, and which assays. (September 2013) Authors: Lindhoff-Last, Edelgard; Ansell, Jack; Spiro, Theodore; Samama, Meyer Michel Journal: Annals of medicine Issue: Volume 45:Number 5/6(2013) Page Start: 423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗